Related Experiment Video
Updated: Mar 10, 2026

Reconstruct Human Retinoblastoma In Vitro
Published on: October 11, 2022
Role of the RBMS Family in Different Cancers and Research Progress
Hanchi Wu1,2, Rui Hou1,2, Yuhan Zhang1,2
1The Affiliated Wuxi People's Hospital of Nanjing Medical University, Wuxi People's Hospital, Wuxi Medical Center, Nanjing Medical University, Wuxi 214023, China.
Abstract:
RNA-binding proteins (RBPs), as posttranscriptional regulators, can modulate the activity and stability of target RNAs and participate in the whole life cycle of RNA processing, localization, modification and translation. RNA-binding motif single-stranded interacting proteins (RBMSs) comprise a critical subgroup within the RNA-binding protein (RBP) family, sharing the same domain characteristics as other RBPs. Several studies have shown that RBMSs can participate in tumorigenesis and tumor progression through mechanisms such as regulating the expression of oncogenes, growth factors and cell cycle proteins. In this paper, we reviewed the role of RBPs and related research progress in breast, prostate, lung, liver, gastric and colorectal cancers.
Insights
RNA-binding proteins (RBPs) regulate RNA and are crucial in cancer. This review details RNA-binding motif single-stranded interacting proteins (RBMSs) roles in various cancers, including breast, lung, and liver.
Area of Science:
- Molecular Biology
- Oncology
- Biochemistry
Background:
- RNA-binding proteins (RBPs) are key posttranscriptional regulators controlling RNA processing, localization, modification, and translation.
- RNA-binding motif single-stranded interacting proteins (RBMSs) are a vital subgroup of RBPs implicated in cellular processes.
- RBMSs have been linked to tumorigenesis and cancer progression by influencing oncogenes, growth factors, and cell cycle proteins.
Purpose of the Study:
- To review the multifaceted roles of RBPs in cancer.
- To highlight the specific involvement of RBMSs in various cancer types.
- To summarize current research progress on RBPs in oncological diseases.
Main Methods:
- Literature review and synthesis of existing research.
- Analysis of studies focusing on RBPs and RBMSs in cancer.
- Compilation of data on RBP functions in specific cancer types.
Main Results:
- RBPs significantly impact RNA metabolism and gene expression.
- RBMSs play critical roles in the development and progression of multiple cancers.
- Evidence links RBPs to oncogenesis through regulation of key cancer-related genes and proteins.
Conclusions:
- RBPs, particularly RBMSs, are important therapeutic targets in oncology.
- Further research into RBP functions can uncover novel strategies for cancer treatment.
- Understanding RBP roles is crucial for advancing cancer research and patient care.
Related Concept Videos
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Negative Regulator Molecules
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
The Ras Gene
Ras is a...
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...

